Recall events
/
Event 61802
Event summary
Timeline bucket May 01, 2012
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Ben Venue Laboratories Inc
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Midazolam HCl Injection, 5 mg/mL, 1 mL single use vials, packaged in 10 x 1 mL single use vials per pack, Rx only, Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; Manufactured for: Bedford Laboratories, Bedford, OH 44146, NDC 55390-138-01; UPC 3 55390-138-01 8.
D-1376-2012
Recall number D-1376-2012
Initiated May 01, 2012
Classification Class II
Status Terminated
Quantity 11,161 packs
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
Code information Lot #1856177, Exp 06/30/13
Distribution pattern Nationwide and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2775]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1.
D-1377-2012
Recall number D-1377-2012
Initiated May 01, 2012
Classification Class II
Status Terminated
Quantity 6,515 packs
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
Code information Lot # 2006500, Exp 08/31/12
Distribution pattern Nationwide and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4310]
FDA event record
· Exact recall-number query on openFDA
